The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Spatially defined enrichment of a neuronal-like malignant phenotype in pancreatic cancer after neoadjuvant treatment.
 
William L. Hwang
Travel, Accommodations, Expenses - NanoString Technologies
 
Karthik Jagadeesh
No Relationships to Disclose
 
Jimmy Guo
No Relationships to Disclose
 
Hannah I. Hoffman
No Relationships to Disclose
 
Payman Yadollahpour
No Relationships to Disclose
 
Jason Reeves
Employment - NanoString Technologies
 
Prajan Divakar
Employment - NanoString Technologies
 
Toni Delorey
No Relationships to Disclose
 
Arnav Mehta
Stock and Other Ownership Interests - Abata Therapeutics; Asher Biotherapeutics
Consulting or Advisory Role - Abata Therapeutics; Asher Biotherapeutics; Checkmate Pharmaceuticals; Rheos Medicines; Third Rock Ventures
 
Jaimie Lynn Barth
No Relationships to Disclose
 
Piotr Zelga
No Relationships to Disclose
 
Theodore S. Hong
Stock and Other Ownership Interests - PanTher Therapeutics
Consulting or Advisory Role - Boston Scientific; Merck; Novocure; Syndax; Synthetic Biologics
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); IntraOp (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)
 
Rakesh K. Jain
Leadership - Tekla Capital Management; Tekla Capital Management; Tekla Capital Management; Tekla Capital Management
Stock and Other Ownership Interests - Accurius; Enlight Biosciences; Ophthotech; SynDevRx
Honoraria - Amgen
Consulting or Advisory Role - Accurius; Chugai Pharma USA; Ellipses Pharma; Merck; Ophthotech; Pfizer; PureTech; SPARC; SynDevRx
Research Funding - Boehringer Ingelheim
 
Andrew Aguirre
Honoraria - Phillips Gilmore Oncology
Consulting or Advisory Role - Alcon (I); Arrakis Therapeutics; Merck; Syros Pharmaceuticals
Research Funding - Deerfield Management; Mirati Therapeutics; Novo Ventures; Revolution Medicines; Syros Pharmaceuticals
 
Carlos Fernandez Del-Castillo
No Relationships to Disclose
 
Mari Mino-Kenudson
Consulting or Advisory Role - AstraZeneca/MedImmune; H3 Biomedicine
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Elsevier
 
Andrew Liss
No Relationships to Disclose
 
David Tsai Ting
Leadership - PanTher Therapeutics
Stock and Other Ownership Interests - PanTher Therapeutics; ROME Therapeutics; TellBio
Consulting or Advisory Role - Foundation Medicine; Millipore; NanoString Technologies; Pfizer; ROME Therapeutics; Third Rock Ventures
Research Funding - ACD Biotechne (Inst); PureTech (Inst); Ribon Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent License to PanTher Therapeutics (Inst); Patent License to TellBio Inc. (Inst); Patent licensed to Rome Therapeutics by my Institution. (Inst)
 
Aviv Regev
Employment - Genentech
Stock and Other Ownership Interests - Celsius Therapeutics
 
Tyler Jacks
Leadership - Amgen; Dragonfly Therapeutics; Skyhawk Therapeutics; SQZ Biotech; Thermo Fisher Scientific
Stock and Other Ownership Interests - Dragonfly Therapeutics; T2 Biosystems